IL189459A - Use of triazole history to prepare a drug for the treatment and prevention of disease, a number of such history and a pharmaceutical composition containing a number of these - Google Patents

Use of triazole history to prepare a drug for the treatment and prevention of disease, a number of such history and a pharmaceutical composition containing a number of these

Info

Publication number
IL189459A
IL189459A IL189459A IL18945908A IL189459A IL 189459 A IL189459 A IL 189459A IL 189459 A IL189459 A IL 189459A IL 18945908 A IL18945908 A IL 18945908A IL 189459 A IL189459 A IL 189459A
Authority
IL
Israel
Prior art keywords
compounds
prophylaxis
medicament
disorders
treating
Prior art date
Application number
IL189459A
Other languages
English (en)
Hebrew (he)
Other versions
IL189459A0 (en
Original Assignee
Centre Nat Rech Scient
Univ Montpellier Ii
Univ Montpellier I
Aeterna Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05017732A external-priority patent/EP1757290A1/en
Application filed by Centre Nat Rech Scient, Univ Montpellier Ii, Univ Montpellier I, Aeterna Zentaris Gmbh filed Critical Centre Nat Rech Scient
Publication of IL189459A0 publication Critical patent/IL189459A0/en
Publication of IL189459A publication Critical patent/IL189459A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • A61K31/497Non-condensed pyrazines containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL189459A 2005-08-15 2008-02-12 Use of triazole history to prepare a drug for the treatment and prevention of disease, a number of such history and a pharmaceutical composition containing a number of these IL189459A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US70794105P 2005-08-15 2005-08-15
EP05017732A EP1757290A1 (en) 2005-08-16 2005-08-16 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors
US78754306P 2006-03-31 2006-03-31
PCT/EP2006/007945 WO2007020013A2 (en) 2005-08-15 2006-08-11 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors

Publications (2)

Publication Number Publication Date
IL189459A0 IL189459A0 (en) 2008-12-29
IL189459A true IL189459A (en) 2015-08-31

Family

ID=41168847

Family Applications (1)

Application Number Title Priority Date Filing Date
IL189459A IL189459A (en) 2005-08-15 2008-02-12 Use of triazole history to prepare a drug for the treatment and prevention of disease, a number of such history and a pharmaceutical composition containing a number of these

Country Status (4)

Country Link
HK (1) HK1121681A1 (no)
IL (1) IL189459A (no)
NO (1) NO342380B1 (no)
RU (1) RU2415134C9 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016130901A2 (en) * 2015-02-12 2016-08-18 University Of Southern California Blockers of the growth hormone receptor in disease prevention and treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518292B1 (en) * 1999-03-12 2003-02-11 Bristol-Myers Squibb Co. Heterocyclic aromatic compounds usefuls as growth hormone secretagogues
DE60038498T2 (de) * 1999-11-15 2009-05-07 Janssen Pharmaceutica N.V. Triazole als Farnesyltransferaseinhibitoren

Also Published As

Publication number Publication date
HK1121681A1 (en) 2009-04-30
NO20081248L (no) 2008-05-05
RU2008109929A (ru) 2009-09-27
NO342380B1 (no) 2018-05-14
IL189459A0 (en) 2008-12-29
RU2415134C2 (ru) 2011-03-27
RU2415134C9 (ru) 2011-05-27

Similar Documents

Publication Publication Date Title
IL183108A (en) Triazole Compounds, Containing and Using Pharmaceutical Preparations for the Treatment of Prosperity Irregularities
IL184148A (en) History of triazole is claimed as oxytocin antagonists, their pharmacological preparations and their use in the preparation of drugs for the treatment of disorders in which the inhibition of oxytocin gives a beneficial effect
IL202158A (en) History of Oxadiazole, Pharmaceuticals Containing Them and Their Use in the manufacture of Drugs for the Treatment of Neurological and Psychiatric Disorders
IL195142A (en) Processed arylaimidazolone and triazolone, their preparation process, pharmaceutical preparations containing them for the treatment or prevention of diseases
IL192763A (en) History of pyrimidine, preparations containing them and used in the preparation of cancer drugs
IL189578A (en) Pyridine derivatives, pharmaceutical compounds containing them, and their use in the preparation of drugs for the treatment of cns diseases
IL179714A (en) Pharmaceutical preparation containing a history of 2-biphenyl-4-ram-3,2-dehydro-1h-quinazoline-4-on and its use in the preparation of cancer drugs and blood vessel formation
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
IL206296A (en) History of aminopyrazole, and their medicinal products and their use in the preparation of drugs for the prevention and treatment of diseases
HK1092722A1 (en) Pharmaceutical compositions and their use for manufacturing the medicament for treating atherosclerosis, dyslipidemias and related conditions
HK1166983A1 (zh) 包含用於治療疾病或紊亂的化合物的固體形式,其組合物,及其用途
IL194678A (en) Kinase inhibitors, pharmaceutical preparations containing them and their uses in the preparation of a drug for the treatment of cancer in mammals
IL193762A (en) The effective compounds in inhibiting dgat1-related disorders, their medicinal products and their use in the preparation of drugs
IL231576A (en) Derivatives of adamantyl-acetamide, the pharmaceutical compositions containing them and their use in the preparation of medicines
IL181304A (en) Use of dihydroprididone for the preparation of a drug for the treatment of spinal cord dysplasia
IL199362A (en) Pyridopyrimidine Compounds, Pharmaceuticals, Compounds for Use as a Drug, and Compounds for Manufacture @ Drug
IL186303A (en) 1h - benzamideimzole - 4 carboxyamides converted with quarterly carbon in position 2, the pharmaceutical composition containing it and its use for the preparation of a drug @ for the treatment @ of cancer
IL200212A (en) Heterocyclic carboxamide compounds, pharmaceuticals containing them, and their use in the manufacture of drugs to treat or reduce the severity or disease of the cancer and arthritis
IL181524A (en) Heterocyclic compounds, pharmaceuticals containing them and their use in the preparation of drugs
IL206399A (en) Amino triazole history, a pharmaceutical composition containing them and their use in the preparation of a drug
IL185462A0 (en) New pharmaceutical compositions useful in the treatment of pain
IL184712A (en) History of pyrzulo-pyrimidine, process of preparation, medicinal preparations containing them and use of pharmaceutical preparations
WO2006116221A3 (en) Therapeutic combinations for the treatment or prevention of psychotic disorders
IL202505A (en) 2-oxo-3-benzyl-benzoxazole-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumors, drugs containing them and their uses
IL191310A (en) A variant of the factor xa enhancer hemostasis, a pharmaceutical product containing it, and its use in the preparation of drugs for the treatment of hemostasis-related diseases

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed